|
US5846983A
(en)
*
|
1996-02-09 |
1998-12-08 |
Mayo Foundation For Medical Education And Research |
Colonic delivery of nicotine to treat inflammatory bowel disease
|
|
AU752802C
(en)
*
|
1997-11-14 |
2006-04-13 |
Pacira Pharmaceuticals, Inc. |
Production of multivesicular liposomes
|
|
CA2322641C
(en)
|
1998-03-23 |
2010-02-16 |
General Mills, Inc. |
Encapsulation of components into edible products
|
|
AUPP627498A0
(en)
|
1998-10-02 |
1998-10-22 |
University Of Queensland, The |
Novel peptides - i
|
|
DE19847715A1
(de)
*
|
1998-10-16 |
2000-04-20 |
Lohmann Therapie Syst Lts |
Verfahren zur Behandlung der Schizophrenie sowie Mittel zur Verwendung in diesem Verfahren
|
|
ES2226933T3
(es)
*
|
1999-11-01 |
2005-04-01 |
John Rhodes |
Composicion para tratar el estreñimiento y el sindrome del intestino irritable.
|
|
US6468568B1
(en)
|
2000-06-16 |
2002-10-22 |
General Mills, Inc. |
Oligosaccharide encapsulated mineral and vitamin ingredients
|
|
US6436453B1
(en)
|
2000-06-16 |
2002-08-20 |
General Mills, Inc. |
Production of oil encapsulated minerals and vitamins in a glassy matrix
|
|
WO2005039531A1
(en)
|
2003-10-10 |
2005-05-06 |
Antares Pharma Ipl Ag |
Transdermal pharmaceutical formulation for minimizing skin residues
|
|
US7198801B2
(en)
*
|
2000-08-03 |
2007-04-03 |
Antares Pharma Ipl Ag |
Formulations for transdermal or transmucosal application
|
|
EP1307232B1
(en)
*
|
2000-08-03 |
2007-03-07 |
Antares Pharma IPL AG |
Novel composition for transdermal and/or transmucosal administration of active compounds that ensures adequate therapeutic levels
|
|
US20070225379A1
(en)
*
|
2001-08-03 |
2007-09-27 |
Carrara Dario Norberto R |
Transdermal delivery of systemically active central nervous system drugs
|
|
US20040198706A1
(en)
*
|
2003-03-11 |
2004-10-07 |
Carrara Dario Norberto R. |
Methods and formulations for transdermal or transmucosal application of active agents
|
|
US8980290B2
(en)
|
2000-08-03 |
2015-03-17 |
Antares Pharma Ipl Ag |
Transdermal compositions for anticholinergic agents
|
|
CA2341952A1
(en)
*
|
2001-03-23 |
2002-09-23 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory pulmonary diseases
|
|
US7081475B2
(en)
|
2001-09-14 |
2006-07-25 |
Prolx Pharmaceuticals Corp. |
Wortmannin analogs and methods of using same
|
|
US20040037879A1
(en)
*
|
2001-11-02 |
2004-02-26 |
Adusumilli Prasad S. |
Oral controlled release forms useful for reducing or preventing nicotine cravings
|
|
US8557804B2
(en)
|
2002-03-25 |
2013-10-15 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
US8039459B2
(en)
|
2004-07-15 |
2011-10-18 |
Universite Laval |
Nicotinic receptor agonists for the treatment of inflammatory diseases
|
|
WO2004050690A1
(en)
|
2002-12-02 |
2004-06-17 |
Xenome Ltd |
NOVEL χ-CONOTOXIN PEPTIDES (-I)
|
|
EP2412719A1
(en)
|
2002-12-02 |
2012-02-01 |
Xenome Ltd |
Chi-conotoxin peptides
|
|
DE602004030245D1
(de)
|
2003-07-03 |
2011-01-05 |
Sucampo Ag |
Pharmazeutische magensaftresistent überzogene zusammensetzung enthaltend prostaglandin-analoga als chloridkanalöffner
|
|
AU2004259006B2
(en)
|
2003-07-24 |
2010-10-07 |
Glaxosmithkline Llc |
Orally dissolving films
|
|
JP5114631B2
(ja)
*
|
2003-09-01 |
2013-01-09 |
有限会社アーザス |
β−ヒドロキシ短〜中鎖脂肪酸重合体
|
|
WO2006007354A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
A drug/polymer complex, preferably ciprofloxacin/hpmc, its method of manufacturing using lyophilization and its use in an osmotic device
|
|
US8252321B2
(en)
|
2004-09-13 |
2012-08-28 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
|
|
US7780981B2
(en)
|
2004-09-13 |
2010-08-24 |
Chrono Therapeutics, Inc. |
Biosynchronous transdermal drug delivery
|
|
WO2007124250A2
(en)
|
2006-04-21 |
2007-11-01 |
Antares Pharma Ipl Ag |
Methods of treating hot flashes with formulations for transdermal or transmucosal application
|
|
US8067399B2
(en)
|
2005-05-27 |
2011-11-29 |
Antares Pharma Ipl Ag |
Method and apparatus for transdermal or transmucosal application of testosterone
|
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
|
US20070083186A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Darrick Carter |
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
|
|
JP2009509634A
(ja)
*
|
2005-09-30 |
2009-03-12 |
Ｔｔｉ・エルビュー株式会社 |
官能基化マイクロニードル経皮薬剤送達システム、装置及び方法
|
|
US7803413B2
(en)
|
2005-10-31 |
2010-09-28 |
General Mills Ip Holdings Ii, Llc. |
Encapsulation of readily oxidizable components
|
|
WO2008067991A2
(en)
*
|
2006-12-08 |
2008-06-12 |
Antares Pharma Ipl Ag |
Skin-friendly drug complexes for transdermal administration
|
|
CN104224823A
(zh)
|
2007-03-30 |
2014-12-24 |
有限会社爱泽世 |
生酮作用促进剂组合物
|
|
ES2521494T3
(es)
*
|
2007-04-02 |
2014-11-12 |
Parkinson's Institute |
Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
|
|
CN101801359B
(zh)
*
|
2007-05-18 |
2013-11-06 |
Tti优而美株式会社 |
确保有效成分经生物界面增加释放的透皮递送设备
|
|
TW200948383A
(en)
*
|
2008-05-19 |
2009-12-01 |
Univ Nat Taiwan |
System for determining function of intestinal barrier
|
|
US20110268809A1
(en)
|
2010-04-28 |
2011-11-03 |
Paul Andrew Brinkley |
Nicotine-Containing Pharmaceutical Compositions
|
|
US20110274628A1
(en)
|
2010-05-07 |
2011-11-10 |
Borschke August J |
Nicotine-containing pharmaceutical compositions
|
|
EP2654738B1
(en)
*
|
2010-12-21 |
2018-04-18 |
Fertin Pharma A/S |
Chewing gum composition comprising cross-linked polyacrylic acid
|
|
EP2729148A4
(en)
*
|
2011-07-06 |
2015-04-22 |
Parkinson S Inst |
COMPOSITIONS AND METHOD FOR THE TREATMENT OF SYMPTOMS IN PATIENTS WITH MORBUS PARKINSON
|
|
US20130078307A1
(en)
|
2011-09-22 |
2013-03-28 |
Niconovum Usa, Inc. |
Nicotine-containing pharmaceutical composition
|
|
US9907748B2
(en)
|
2011-10-21 |
2018-03-06 |
Niconovum Usa, Inc. |
Excipients for nicotine-containing therapeutic compositions
|
|
US9763928B2
(en)
|
2012-02-10 |
2017-09-19 |
Niconovum Usa, Inc. |
Multi-layer nicotine-containing pharmaceutical composition
|
|
SG11201408251SA
(en)
*
|
2012-06-15 |
2015-01-29 |
Conaris Res Inst Ag |
A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota
|
|
US20150231130A1
(en)
|
2012-07-26 |
2015-08-20 |
Wockhardt Limited |
Pharmaceutical composition comprising diamorphine for intranasal administration
|
|
US20140255452A1
(en)
|
2013-03-11 |
2014-09-11 |
Niconovum Usa, Inc. |
Method and apparatus for differentiating oral pouch products
|
|
ES2788866T3
(es)
|
2013-12-13 |
2020-10-23 |
Conaris Res Institute Ag |
Una composición farmacéutica que contiene ácido nicotínico y/o nicotinamida para su uso en influir beneficiosamente en los niveles de lípidos en sangre mediante la modificación de la microbiota intestinal
|
|
CN105813644B
(zh)
|
2013-12-13 |
2020-07-10 |
康纳里斯研究院股份公司 |
用于有益地影响肠道微生物丛和/或治疗胃肠道炎症的药物组合物
|
|
WO2015191707A2
(en)
*
|
2014-06-10 |
2015-12-17 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Nanoparticulate complex of nicotine and cerium oxide and use thereof
|
|
JP2018511355A
(ja)
|
2015-01-28 |
2018-04-26 |
クロノ セラピューティクス インコーポレイテッドＣｈｒｏｎｏ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｉｎｃ． |
薬剤送達方法及びシステム
|
|
US10679516B2
(en)
|
2015-03-12 |
2020-06-09 |
Morningside Venture Investments Limited |
Craving input and support system
|
|
WO2017048566A1
(en)
*
|
2015-09-15 |
2017-03-23 |
C.B. Fleet Company, Incorporated |
Bisacodyl compositions and delivery apparatus
|
|
US10532046B2
(en)
*
|
2015-12-03 |
2020-01-14 |
Niconovum Usa, Inc. |
Multi-phase delivery compositions and products incorporating such compositions
|
|
US20170165252A1
(en)
|
2015-12-10 |
2017-06-15 |
Niconovum Usa Inc. |
Protein-enriched therapeutic composition
|
|
US10292977B2
(en)
|
2016-04-11 |
2019-05-21 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
US10143687B2
(en)
|
2016-04-11 |
2018-12-04 |
Neurocea, LLC |
Compositions and methods for treatment related to fall and fall frequency in neurodegenerative diseases
|
|
EP3558267B1
(en)
*
|
2016-12-20 |
2023-04-26 |
Fertin Pharma A/S |
A mucoadhesive oromucosal formulation comprising a nicotine complex
|
|
CA3049529A1
(en)
|
2017-01-06 |
2018-07-12 |
Chrono Therapeutics Inc. |
Transdermal drug delivery devices and methods
|
|
US11596779B2
(en)
|
2018-05-29 |
2023-03-07 |
Morningside Venture Investments Limited |
Drug delivery methods and systems
|
|
DK3807260T3
(da)
|
2018-06-15 |
2024-10-14 |
Reynolds Tobacco Co R |
Oprensning af nikotin
|
|
CA3119992A1
(en)
|
2018-11-16 |
2020-05-22 |
Morningside Venture Investments Limited |
Thermally regulated transdermal drug delivery system
|